Hostname: page-component-cd9895bd7-hc48f Total loading time: 0 Render date: 2024-12-27T13:52:12.341Z Has data issue: false hasContentIssue false
  • English
  • Français

Quality of life assessment in patients treated for metastatic cutaneous squamous cell carcinoma of the head and neck

Published online by Cambridge University Press:  05 March 2013

A Y Wang ,
C E Palme ,
J T Wang ,
G J Morgan ,
V Gebski ,
J Gilchrist  and
M J Veness
A Y Wang
Affiliation:
Head and Neck Cancer Service, Westmead Hospital, University of Sydney, New South Wales, Australia
C E Palme
Affiliation:
Head and Neck Cancer Service, Westmead Hospital, University of Sydney, New South Wales, Australia
J T Wang
Affiliation:
Head and Neck Cancer Service, Westmead Hospital, University of Sydney, New South Wales, Australia
G J Morgan
Affiliation:
Head and Neck Cancer Service, Westmead Hospital, University of Sydney, New South Wales, Australia
V Gebski
Affiliation:
Head and Neck Cancer Service, Westmead Hospital, University of Sydney, New South Wales, Australia NHMRC Clinical Trials Centre, University of Sydney, New South Wales, Australia
J Gilchrist
Affiliation:
Head and Neck Cancer Service, Westmead Hospital, University of Sydney, New South Wales, Australia
M J Veness*
Affiliation:
Head and Neck Cancer Service, Westmead Hospital, University of Sydney, New South Wales, Australia
*
Address for correspondence: A/Prof Michael J Veness, Radiation Oncologist, Staff Specialist, Department of Radiation Oncology, Westmead Hospital, Westmead, NSW, Australia 2145 Fax: +61 2 9891 5814 E-mail: michael.veness@swahs.health.nsw.gov.au
Get access Rights & Permissions [Opens in a new window]

Abstract

Background:

Treatment for metastatic cutaneous head and neck squamous cell carcinoma is usually multimodal and associated with morbidity. This study aimed to evaluate the impact of treatment on patients' quality of life.

Method:

Cross-sectional survey of 42 patients (35 men, 7 women) at least 6 months after metastatic cutaneous head and neck squamous cell carcinoma treatment, using two standardised quality of life questionnaires: the Functional Assessment of Cancer Therapy – Head and Neck questionnaire and the Facial Disability Index, with statistical analysis to identify potential predictors of outcome.

Results:

Female gender correlated with significantly lower Facial Disability Index physical function scores (p = 0.017). Alcohol consumption correlated with significantly better scores for Functional Assessment social well-being (p = 0.016), general total score (p = 0.041) and overall total score (p = 0.033), and for Facial Disability Index physical function (p = 0.034). Marital status, education, employment, chemotherapy, time from last treatment, parotidectomy and facial nerve sacrifice did not affect quality of life. The commonest patient complaints were dry mouth (76 per cent), altered voice quality and strength (55 per cent), and physical appearance (45 per cent).

Conclusion:

Female gender predicts worse quality of life, while alcohol consumption (versus none) predicted for better quality of life.

Keywords

Head And NeckCutaneous Squamous Cell CarcinomaMetastasesQuality of LifeOutcomes Assessment, PatientTherapy; Facial Disability Index
Type
Main Articles
Information
The Journal of Laryngology & Otology , Volume 127 , Supplement S2 , July 2013 , pp. S39 - S47
Copyright
Copyright © JLO (1984) Limited 2013 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Footnotes

Presented at the Australasian and New Zealand Head and Neck Cancer Society Annual Scientific Meeting and IFHNOS 2012 World Tour, 26 November 2012, Brisbane, Queensland, Australia

References

1Ramirez, CC, Federman, DG, Kirsner, RS. Skin cancer as an occupational disease: the effect of ultraviolet and other forms of radiation. Int J Dermatol 2005;44:95–100CrossRefGoogle ScholarPubMed
2Veness, MJ, Porceddu, S, Palme, CE, Morgan, GJ. Cutaneous head and neck squamous cell carcinoma metastatic to parotid and cervical lymph nodes. Head Neck 2007;29:621–31CrossRefGoogle ScholarPubMed
3Buettner, PG, Raasch, BA. Incidence rates of skin cancer in Townsville, Australia. Int J Cancer 1998;78:587–933.0.CO;2-E>CrossRefGoogle ScholarPubMed
4Veness, MJ, Palme, CE, Morgan, GJ. High-risk cutaneous squamous cell carcinoma of the head and neck: results from 266 treated patients with metastatic lymph node disease. Cancer 2006;106:2389–96CrossRefGoogle ScholarPubMed
5Wang, JT, Palme, CE, Morgan, GJ, Gebski, V, Wang, AY, Veness, MJ. Predictors of outcome in patients with metastatic cutaneous head and neck squamous cell carcinoma involving cervical lymph nodes: improved survival with the addition of adjuvant radiotherapy. Head Neck 2012;34:1524–8CrossRefGoogle ScholarPubMed
6Veness, MJ, Morgan, GJ, Palme, CE, Gebski, V. Surgery and adjuvant radiotherapy in patients with cutaneous head and neck squamous cell carcinoma metastatic to lymph nodes: combined treatment should be considered best practice. Laryngoscope 2005;115:870–5CrossRefGoogle ScholarPubMed
7Palme, CE, Irish, JC, Gullane, PJ, Katz, MR, Devins, GM, Bachar, G. Quality of life analysis in patients with anterior skull base neoplasms. Head Neck 2009;31:1326–34CrossRefGoogle ScholarPubMed
8Ackerstaff, AH, Rasch, CR, Balm, AJ, de Boer, JP, Wiggenraad, R, Rietveld, DH et al. Five-year quality of life results of the randomized clinical phase III (RADPLAT) trial, comparing concomitant intra-arterial versus intravenous chemoradiotherapy in locally advanced head and neck cancer. Head Neck 2012;34:974–80CrossRefGoogle ScholarPubMed
9List, MA, D'Antonio, LL, Cella, DF, Siston, A, Mumby, P, Haraf, D et al. The performance status for head and neck cancer patients and the Functional Assessment of Cancer Therapy-Head and Neck (FACT-H&N) scale: a study of utility and validity. Cancer 1996;77:2294–3013.0.CO;2-S>CrossRefGoogle Scholar
10Cella, DF, Tulsky, DS, Gray, G, Sarafian, B, Linn, E, Bonomi, A et al. The functional assessment of cancer therapy scale: development and validation of the general measure. J Clin Oncol 1993;11:570–9CrossRefGoogle ScholarPubMed
11VanSwearingen, JM, Brach, JS. The Facial Disability Index: reliability and validity of a disability assessment instrument for disorders of the facial neuromuscular system. Phys Ther 1996;76:1288–98CrossRefGoogle ScholarPubMed
12Matthews, BA, Rhee, JS, Neuburg, M, Burzynski, ML, Nattinger, AB. Development of the facial skin care index: a health-related outcomes index for skin cancer patients. Dermatol Surg 2006;32:924–34CrossRefGoogle ScholarPubMed
13Edge, SB, Byrd, DR, Compton, CC, Fritz, AG, Greene, FL, Trotti, A. AJCC Cancer Staging Handbook: From the AJCC Cancer Staging Manual, 7th edn.New York: Springer-Verlag, 2010Google Scholar
14D'Antonio, LL, Zimmerman, GJ, Cella, DF, Long, SA. Quality of life and functional status measures in patients with head and neck cancer. Arch Otolaryngol Head Neck Surg 1996;122:482–7CrossRefGoogle ScholarPubMed
15Brach, JS, VanSwearingen, J, Delitto, A, Johnson, PC. Impairment and disability in patients with facial neuromuscular dysfunction. Otolaryngol Head Neck Surg 1997;117:315–21CrossRefGoogle ScholarPubMed
16Maciejewski, O, Smeets, R, Gerhards, F, Kolk, A, Kloss, F, Stein, JM et al. Gender specific quality of life in patients with oral squamous cell carcinomas. Head Face Med 2010;6:21CrossRefGoogle ScholarPubMed
17Bjordal, K, Hammerlid, E, Ahlner-Elmqvist, M, de Graeff, A, Boysen, M, Evensen, JF et al. Quality of life in head and neck cancer patients: validation of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-H&N35. J Clin Oncol 1999;17:1008–19CrossRefGoogle ScholarPubMed
18Allison, PJ. Alcohol consumption is associated with improved health-related quality of life in head and neck cancer patients. Oral Oncol 2002;38:81–6CrossRefGoogle ScholarPubMed
19Potash, AE, Karnell, LH, Christensen, AJ, Vander Weg, MW, Funk, GF. Continued alcohol use in patients with head and neck cancer. Head Neck 2010;32:905–12CrossRefGoogle ScholarPubMed
20El-Deiry, M, Funk, GF, Nalwa, S, Karnell, LH, Smith, RB, Buatti, JM et al. Long-term quality of life for surgical and nonsurgical treatment of head and neck cancer. Arch Otolaryngol Head Neck Surg 2005;131:879–85CrossRefGoogle ScholarPubMed
21Campbell, BH, Marbella, A, Layde, PM. Quality of life and recurrence concern in survivors of head and neck cancer. Laryngoscope 2000;110:895–906CrossRefGoogle ScholarPubMed
22Campbell, BH, Spinelli, K, Marbella, AM, Myers, KB, Kuhn, JC, Layde, PM. Aspiration, weight loss and quality of life in head and neck cancer survivors. Arch Otolaryngol Head Neck Surg 2004;130:1100–3CrossRefGoogle ScholarPubMed
23Nordgren, M, Jannert, M, Boysen, M, Ahlner-Elmqvist, M, Silander, E, Bjordal, K et al. Health-related quality of life in patients with pharyngeal carcinoma: a five-year follow-up. Head Neck 2006;28:339–49CrossRefGoogle ScholarPubMed
24Nordgren, M, Hammerlid, E, Bjordal, K, Ahlner-Elmqvist, M, Boysen, M, Jannert, M. Quality of life in oral cancer: a 5-year prospective study. Head Neck 2008;30:461–70CrossRefGoogle ScholarPubMed
25Shah, S, Har-El, G, Rosenfeld, RM. Short-term and long-term quality of life after neck dissection. Head Neck 2001;23:954–61CrossRefGoogle ScholarPubMed